RSH

0.00%

3.7¢ respiri limited

Product tests & clinical results, facts please, page-35

First 35 Last

Share
Profile

Follow
btstech

40 Posts.

29/10/20

21:15

Post #: 48506266
Share

Originally posted by Richney: ↑

AlCP,
You aren't seeing anything other than mindnumbing ramblings. You don't see my point of view because you have never used Wheezo, aren't a carer of an asthmatic child and have no concept or experience in chronic disease management in the real world. I keep saying your lack of understanding is breathtaking however it is now bordering on simply dangerous.

According to what you say in your post.....I was thinking it would be more useful to know if the wheeze has caused any asthma complication or severity which only a spirometry can detect you are actually stating that you want a technology to be useful only AFTER an asthma complication or attack has occurred!! So, after a child is in the ER, your simple mind thinks that when the technology is at its most useful to understand how severe the wheeze is....i can tell you, you don't need any technology to tell you how severe something once you are in the ER, because you are in the ER in the first place!

I determine who successful the Wheezo system is in monitoring and managing my sons asthma by how many exacerbations, attacks and visits to the ER he has had since being diagnosed with asthma.....do you know how many he has had - ZERO! In your simple mind you might think Wheezo screens for wheeze (again breathtaking lack of understanding), it does soooo much more than that. RAP may screen or just indicate the presence of something with its concept. Wheezo doesn't provide a screen (ie. do you have it or not) It provides an objective measure of the % amount of Wheeze per breath cycle (i.e. 18%, 12%) that can allow an asthmatic to understand their level of Wheezing, whether it is increasing or deacreasing over multiple measurement and data points and make an OBJECTIVE assessment as to whether their asthma is under control or whether they are at risk of an exacerbation from gradually increasing wheezing in their breathing that requires medication to be administered.

I HAVE CLEARLY EXPLAINED THIS IN MY PREVIOUS POSTS THAT YOU OBVIOUSLY TRULY DON'T UDNERSTAND HOWEVER I HOPE PROVIDE OTHERS WITH A DETAILED UNDERSTANDING OF THE BENEFITS OF WHEEZO AS THE WORLD LEADING MONITORING AND MANANGEMENT SYSTEM FOR ASTHMATICS.

Expand

You are a Very patient person @Richney if he doesn't get it now he is just winding you up!!

RSH Price at posting: 17.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 10 more messages in this thread...

First 35 Last

Add RSH (ASX) to my watchlist

(20min delay)
Last 3.7¢		Change 0.000(0.00%)		Mkt cap ! $47.53M

Open	High	Low	Value	Volume
3.6¢	3.7¢	3.6¢	$4.921K	135.6K

Buyers (Bids)

No.	Vol.	Price($)
2	80000	3.6¢

Sellers (Offers)

Price($)	Vol.	No.
3.7¢	45178	1

View Market Depth

No.	Vol.	Price($)
1	30000	0.036
4	353545	0.035
1	100000	0.034
2	100000	0.033
3	541370	0.032

Price($)	Vol.	No.
0.037	45178	1
0.038	515624	2
0.039	1482602	2
0.040	840000	3
0.042	882000	1

Last trade - 16.10pm 27/09/2024 (20 minute delay)

RSH (ASX) Chart

Product tests & clinical results, facts please, page-35

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Product tests & clinical results, facts please, page-35

Top Stories

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News